Dr. Kumar’s Take:
This small pilot study suggests that azithromycin, a common antibiotic, may reduce OCD symptoms in children with PANS, especially if tics are also present. Results were mixed across the two rating scales used, so I read this as an early signal rather than settled practice.
Key Takeaways:
✔ Azithromycin led to a stronger drop in OCD symptoms on one key clinical scale.
✔ More kids in the azithromycin group met the “treatment responder” criteria.
✔ Children with greater tic severity showed a stronger treatment response.
✔ Azithromycin was well tolerated, but a trend toward a longer QTc means caution is needed.
Actionable Tip:
If your child has sudden-onset OCD and tics, ask your doctor whether a short course of azithromycin might be worth exploring.
What This Study Looked At:
Researchers ran a double-blind, randomized, placebo-controlled pilot trial in 31 youth aged 4 to 14 who had acute-onset OCD meeting criteria for pediatric acute-onset neuropsychiatric syndrome, a presentation the authors describe as possibly secondary to infectious or immune-mediated triggers. Participants were randomized to azithromycin or placebo for 4 weeks. The goal was to assess preliminary efficacy, tolerability, and safety.
All participants also took twice-daily probiotics during the study.
Study Design:
- Participants: 31 youth with PANS (62.5% male, mean age 8.26 ± 2.78 years)
- Treatment: Azithromycin (10 mg/kg daily, up to 500 mg) or placebo for 4 weeks, with 17 in the azithromycin group and 14 on placebo
- Measures Used:
- CGI-S OCD: Clinical rating of OCD severity
- CY-BOCS: The Children’s Yale-Brown Obsessive Compulsive Scale
- CGI-I OCD: A rating of improvement
What They Found:
- OCD severity dropped more on the CGI-S scale in the azithromycin group compared to placebo after treatment (p = 0.003)
- More children met responder criteria on the CGI-I OCD at the end of week 4 in the azithromycin group (41.2%, n = 7, vs. 7.1%, n = 1; p = 0.045)
- No significant difference on the CY-BOCS scale
- Tic severity moderated treatment response, with greater tic severity associated with an enhanced response on the CGI-S OCD
- Minimal adverse effects and no dropouts due to side effects, though the azithromycin group had significantly more reports of loose or abnormal stools (p = 0.009) and a trend toward a greater QTc on electrocardiography at the end of week 4 (p = 0.060)
Why Azithromycin Might Help OCD in PANS
The authors’ premise is that sudden, severe OCD can arise secondary to infectious or immune-mediated triggers. Treating the infection with an antibiotic is one way to test that premise, and in this trial the children who improved most were those carrying both OCD and tic symptoms. The study was not designed to isolate the mechanism, so I would treat any explanation as a hypothesis under test.
Related Studies and Research
PANS Treatment: Large Survey Study: Examines treatment trends and outcomes in a large community-based sample.
IVIG for PANDAS: Pediatric OCD Trial: Reviews IVIG’s effectiveness in a randomized trial.
PANDAS Strep Antibiotic Recovery Study: Details how antibiotics affected symptom recurrence post-strep infection.
Podcast: Could Your Child’s Behavior Changes Be Cured with an Antibiotic?: A deep dive into the link between strep infections and dramatic neuropsychiatric symptoms.
Frequently Asked Questions
What is PANS?
PANS stands for pediatric acute-onset neuropsychiatric syndrome. It describes children whose OCD begins suddenly and severely, a presentation the study authors note may follow infectious or immune-mediated triggers.
Why use an antibiotic for OCD?
Because acute-onset OCD may present secondary to an infection or the immune response to one, treating with an antibiotic is a way to target the suspected trigger rather than the symptoms alone.
Is azithromycin safe for kids?
In this trial it was well tolerated, with minimal adverse effects and no dropouts due to side effects. Loose or abnormal stools were more common on azithromycin, and there was a trend toward a greater QTc, a measure of cardiac conduction. The authors concluded that the potential for cardiac risks means additional monitoring may be needed.
What if my child doesn’t have tics?
Greater tic severity was associated with a stronger response in this study. That does not rule out benefit for children without tics, and larger trials are needed to define who responds best.
Conclusion
This double-blind pilot study suggests azithromycin may be helpful in youth meeting the PANS diagnosis, especially those with elevated levels of both OCD and tic symptoms. It was well tolerated, but the possibility of cardiac risk means it belongs under a doctor’s supervision with appropriate monitoring.
